ADH1A and hepatocellular carcinoma: In Gao’s cohort, researchers identified pyrroline-5-carboxylate reductase 2 (PYCR2) and alcohol dehydrogenase 1A (ADH1A) as biomarkers of poor and good prognosis in HCC patients, respectively [25].